Disclosures: Amalia Tzoumpa: Nothing to Disclose, Beatriz Lozano-Ruiz: Nothing to Disclose, ALBA Moratalla: Nothing to Disclose, Mara Teresa Pomares: Nothing to Disclose, Ivan Herrera: Nothing to Disclose, Joanna Pico: Nothing to Disclose, Yin Huang: Nothing to Disclose, Juanjo Lozano: Nothing to Disclose, Pablo Bellot: Nothing to Disclose, Sonia Bartolom: Nothing to Disclose, Pedro Zapater: Nothing to Disclose, Jose Manuel Gonzlez-Navajas: Nothing to Disclose 2596 MEASUREMENT OF EFFECTIVE ALBUMIN CONCENTRATION SIGNIFICANTLY IMPROVED PREDICTION OF ONE YEAR MORTALITY IN PATIENTS WITH ACUTELY DECOMPENSATED CIRRHOSIS WITHOUT ACUTE-ON-CHRONIC LIVER FAILURE Chenxi Zhang 1 Shuang Meng 2 Yide Lu 1 Yaoxing Chen 1 Minghao Cai 1 Haoshuang Fu 1 Jie Lu 1 Ziqiang Li 1 Zhuping Qian 1 Baoyan An 1 Haiguang Xin 1 Li Xia 3 Zhujun Cao 1 Qing Xie 1 , 1 Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, 2 Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, China, 3 Shanghai Jiao Tong University School of Medicine, Shanghai, China Background Evaluation of effective albumin (eAlb) as opposed to routine serum albumin has recently shown prognostic value on short-term outcome of patients with acute decompensation (AD) of cirrhosis due to a closer association of eAlb with disease severity and albumin dysfunction
E.BiggsJ
10.1038/nm1021 178 KilloyK
P.JadhavA
doi: 10.3109/09273948.2011.618902 39 McGeachyMJCuaDJGaffenSL
